A clinical trial considered the "gold standard" for clinical investigation has concluded that "no benefit" of hydroxychloroquine was found on patients hospitalised with the coronavirus, researchers said on Friday.

Major trial says 'no benefit' of Trump-backed hydroxychloroquine

As US President Donald Trump continues to back the anti-malarial drug hydroxychloroquine as a potential treatment to novel coronavirus, a new study has claimed that the drug does not avoid infection in a statistically meaningful way.

New study says Trump-backed hydroxychloroquine no better than placebo

Despite the World Health Organization dropping hydroxychloroquine from its study into experimental coronavirus treatments, a White House official said that the US president is feeling "absolutely great" after taking a two-week dose of the drug.

Donald Trump feeling 'absolutely great' after taking hydroxychloroquine: White House official